Enquete Commission. A report from Germany — an extract from the prospects and risks of gene technology: the report of the Enquete commission to the Bundestag of the Federal Republic of Germany. Bioethics 2:254-263; 1988.
Curren T. Human gene therapy. Ottawa: Library of Parliament Research Branch, 1989.
Anderson WF. Human gene therapy: why draw a line? Journal of Medicine and Philosophy 14:681-693; 1989.
U.S. Congress, Office of Technology Assessment. New developments in biotechnology—background paper: public perceptions of biotechnology. Washington, DC: U.S. Government Printing Office, 1987.
Royal Commission on New Reproductive Technologies. Gene therapy and genetic alteration. In: Proceed with care: final report of the Royal Commission on new reproductive technologies (vol 2). Ottawa: Minister of Government Services Canada, 1993.
Berger EM, Gert BM. Genetic disorders and the ethical status of germ-line gene therapy. Journal of Medicine and Philosophy 16(6): 667-683; 1991.
Blaese RM, Culver KW, Miller AD, et al. T lymphocyte directed gene therapy for ADA-SCID: initial results after 4 years. Science 270(5235): 475-480; 1995.
Caplan AL. If gene therapy is the cure, what is the disease? In: Annas GJ, Elias S, editors. Gene mapping: using law and ethics as guides. Oxford, UK: Oxford University Press, 1992.
DeWachter MAM. Ethical aspects of human germ-line gene therapy. Bioethics 7:166-177; 1993.
Fletcher JC, Anderson WF. Germ-line gene therapy: a new stage of debate. Law, Medicine and Health Care 20(1-2): 26-39; 1992.
Norman C. Clerics urge ban on altering germline cells. Science 220(4604): 1360-1361; 1983.
Latchman DS. Germline gene therapy? Gene Therapy 1(5): 277-279; 1994.
Procter RN. Genomics and eugenics. In: Annas GJ, Elias S, editors. Gene mapping: using law and ethics as guides. Oxford, UK: Oxford University Press, 1992.
Appel A. Embryo research faces a renewed ban in the US. Nature 376(6538): 288; 1995.
Elias S, Annas GJ. Somatic and germline gene therapy. In: Annas GJ, Elias S, editors. Gene mapping: using law and ethics as guides. Oxford, UK: Oxford University Press, 1992.
Fletcher JC. Ethical issues in and beyond prospective clinical trials of human gene therapy. Journal of Medicine and Philosophy 10(3): 293-309; 1985.
Schnieke AE, Kind AJ, Ritchie WJ, Mycock K, Scott AR, Ritchie M, Wilmut I, Colman A, Campbell KH. Human factor IX transgenic sheep produced by transfer of nuclei from transfected fetal fibroblasts. Science 278(5346): 2130-2133;1997.
Prior L. Somatic and germ line gene therapy: current status and prospects. In: Research volumes of the Royal Commission on new reproductive technologies (vol 14). Ottawa: Minister of Government Services Canada, 1993.
Fletcher JC, Ritcher G. Human fetal gene therapy: moral and ethical questions. Human Gene Therapy 7(13): 1605-1614;1996.
Steele CD, Wapner RJ, Smith JB, Haynes MK, Jackson LG. Peripheral diagnosis using fetal cells isolated from maternal peripheral blood: a review. Clinics in Obstetrics and Gynecology 39:801-813; 1996.
